Article may be outdated

This article is 20 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
The Hindu·3 min read·medium

Thai FDA approves new treatment for gonorrhoea

T
The Hindu Bureau
Thai FDA approves new treatment for gonorrhoea
✦AI Summary

Thailand's FDA has approved Nuzolvence (zoliflodacin), a new oral antibiotic designed to treat uncomplicated urogenital gonorrhoea. Developed through a partnership between GARDP, Dr. Reddy’s Laboratories, and Innoviva, the drug offers a critical new option for addressing multidrug-resistant strains.

Why it mattersUnlock →

Thailand’s Food and Drug Administration has approved Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for the treatment of uncomplicated urogenital gonorrhoea for which Dr. Reddy’s Laboratories with support from The GARDP Foundation had led the priority review submission.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthsciencebusiness
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in